A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma
Clinical trial NCT04434469 · COMPLETED
Trial details
- NCT number
- NCT04434469
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2022-02-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.